These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11656915)

  • 1. IRBs and randomized clinical trials.
    Meinert CL
    IRB; 1998; 20(2-3):9-12. PubMed ID: 11656915
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM; Sugarman J; Kass N
    IRB; 1998; 20(1):1-5. PubMed ID: 11655324
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
    Gordon B; Prentice E
    IRB; 1997; 19(2):8-11. PubMed ID: 11655323
    [No Abstract]   [Full Text] [Related]  

  • 5. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 6. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD
    IRB; 1993; 15(5):1-7. PubMed ID: 11659703
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical and legal considerations in dental caries research involving human subjects.
    Branson R
    J Dent Res; 1980 Jul; 59(Special Issue C):1214-364. PubMed ID: 11651755
    [No Abstract]   [Full Text] [Related]  

  • 8. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 9. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 11. Human experimentation: the review process in practice.
    Cowan DH
    Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165
    [No Abstract]   [Full Text] [Related]  

  • 12. IRBs and epidemiologic research: how inappropriate restrictions hamper studies.
    Cann CI; Rothman KJ
    IRB; 1984; 6(4):5-7. PubMed ID: 11649562
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on the PEG-SOD study involving incompetent subjects: FDA permits an exception to informed consent requirements.
    Prentice ED; Antonson DL; Leibrock LG; Prabhu VC; Kelso TK; Sears TD
    IRB; 1994; 16(1-2):16-8. PubMed ID: 11652322
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing federal regulation of IRBs, Part III: social research and the proposed DHEW regulations.
    Gray BH
    IRB; 1980 Jan; 2(1):1-5+. PubMed ID: 11661793
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective review of external adverse events: one IRB's response to the avalanche of IND safety reports.
    Gordon B; Prentice E
    IRB; 1999; 21(3):10-1. PubMed ID: 11657877
    [No Abstract]   [Full Text] [Related]  

  • 16. Half-full or half-empty? Evaluating IRB performance.
    Mishkin B; Ariand N
    Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual review: observed deficiencies and suggested corrections.
    Adams MS; Conrad DA
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract]   [Full Text] [Related]  

  • 18. Protecting research subjects after consent: the case for the "research intermediary.
    Reiser SJ; Knudson P
    IRB; 1993; 15(2):10-1. PubMed ID: 11651567
    [No Abstract]   [Full Text] [Related]  

  • 19. An IRB member's perspective on access to innovative therapy.
    Moore DL
    Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
    [No Abstract]   [Full Text] [Related]  

  • 20. Commission says institutional review boards should change procedures now.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.